Comparative study of Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade

Not Applicable

• Conditions: Respiratory; lung biopsy

• Registration Number: PACTR201510001292136
• Lead Sponsor: shahira el metainy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-10-03
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

ASA III&IV adult patients
over 60 years
undergo bronchoscopic lung biopsy

Exclusion Criteria

a difficult airway
known or suspected neuromuscular disorders significant renal dysfunction
patients receiving medication likely to interfere with rocuronium

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
is to measure the time to reach train-of-four > 0.9

Secondary Outcome Measures

Name	Time	Method
blood gas analysis ;peak expiratory flow rate ;Symptoms of pulmonary complications